Skip to content
Opens in a new window
Episode 161: How to Build a Clinical-Stage Biotech Company Without Venture Capital
04 November 2026

Episode 161: How to Build a Clinical-Stage Biotech Company Without Venture Capital

BIO from the BAYOU: Build Your Biotech Network with Key Opinion Leaders and Investors

About

Can you take a biotech company from an early scientific discovery to clinical trials without giving up equity to investors?

In this episode, host Elaine Hamm, PhD, sits down with Nazneen Dewji, PhD, Founder and CEO of Cenna Biosciences and a finalist in the BioChallenge Pitch Competition, to discuss her company's innovative approach to Alzheimer's disease and her unconventional path to biotech entrepreneurship. Nazneen shares how she leveraged NIH grants and other non-dilutive funding to advance Cenna Biosciences from early research to an IND clearance for Phase 1 clinical trials, all without traditional venture capital investment.

In this episode, you'll discover:

    How Cenna Biosciences is approaching Alzheimer's disease by targeting amyloid-beta production rather than removing existing plaques, and what that could mean for future treatments.

    Why NIH grants, SBIR funding, and other non-dilutive financing opportunities can help biotech startups advance drug development while retaining equity.

    What academic researchers should consider before launching a biotech company, including the challenges of transitioning from academia to entrepreneurship and learning the business side of science.

Tune in to discover how innovative science, strategic grant funding, and entrepreneurial determination can help turn academic research into a clinical-stage biotech company without relying on traditional venture capital.

Links: 

Connect with Nazneen Dewji, PhD, and learn about Cenna Biosciences.

Connect with Elaine Hamm, PhD, and learn about Tulane Medicine Business Development and the School of Medicine.

Check out the New Orleans BioInnovation Center and their BioChallenge Pitch Competition.

Connect with James Zanewicz, JD, LLM, RTTP, and learn about Connect.

Check out the book Dual Fluency.

Connect with Ian McLachlan, BIO from the BAYOU producer.

Learn more about BIO from the BAYOU - the podcast.

 

Bio from the Bayou is a podcast that explores biotech innovation, business development, and healthcare outcomes in New Orleans & The Gulf South, connecting biotech companies, investors, and key opinion leaders to advance medicine, technology, and startup opportunities in the region.